155 related articles for article (PubMed ID: 24902043)
1. Novel human butyrylcholinesterase variants: toward organophosphonate detoxication.
Dwyer M; Javor S; Ryan DA; Smith EM; Wang B; Zhang J; Cashman JR
Biochemistry; 2014 Jul; 53(27):4476-87. PubMed ID: 24902043
[TBL] [Abstract][Full Text] [Related]
2. Nerve agent analogues that produce authentic soman, sarin, tabun, and cyclohexyl methylphosphonate-modified human butyrylcholinesterase.
Gilley C; MacDonald M; Nachon F; Schopfer LM; Zhang J; Cashman JR; Lockridge O
Chem Res Toxicol; 2009 Oct; 22(10):1680-8. PubMed ID: 19715348
[TBL] [Abstract][Full Text] [Related]
3. Identification of human butyrylcholinesterase organophosphate-resistant variants through a novel mammalian enzyme functional screen.
Zhang J; Chen S; Ralph EC; Dwyer M; Cashman JR
J Pharmacol Exp Ther; 2012 Dec; 343(3):673-82. PubMed ID: 22956723
[TBL] [Abstract][Full Text] [Related]
4. Chemical synthesis of two series of nerve agent model compounds and their stereoselective interaction with human acetylcholinesterase and human butyrylcholinesterase.
Barakat NH; Zheng X; Gilley CB; MacDonald M; Okolotowicz K; Cashman JR; Vyas S; Beck JM; Hadad CM; Zhang J
Chem Res Toxicol; 2009 Oct; 22(10):1669-79. PubMed ID: 19715346
[TBL] [Abstract][Full Text] [Related]
5. Degradation of nerve agents by an organophosphate-degrading agent (OpdA).
Dawson RM; Pantelidis S; Rose HR; Kotsonis SE
J Hazard Mater; 2008 Sep; 157(2-3):308-14. PubMed ID: 18258361
[TBL] [Abstract][Full Text] [Related]
6. Structural and kinetic evidence of aging after organophosphate inhibition of human Cathepsin A.
Bouknight KD; Jurkouich KM; Compton JR; Khavrutskii IV; Guelta MA; Harvey SP; Legler PM
Biochem Pharmacol; 2020 Jul; 177():113980. PubMed ID: 32305437
[TBL] [Abstract][Full Text] [Related]
7. Substrate Analogues for the Enzyme-Catalyzed Detoxification of the Organophosphate Nerve Agents-Sarin, Soman, and Cyclosarin.
Bigley AN; Harvey SP; Narindoshvili T; Raushel FM
Biochemistry; 2021 Sep; 60(38):2875-2887. PubMed ID: 34494832
[TBL] [Abstract][Full Text] [Related]
8. Currently used cholinesterase reactivators against nerve agent intoxication: comparison of their effectivity in vitro.
Kuca K; Jun D; Bajgar J
Drug Chem Toxicol; 2007; 30(1):31-40. PubMed ID: 17364862
[TBL] [Abstract][Full Text] [Related]
9. Formation of pyrophosphate-like adducts from nerve agents sarin, soman and cyclosarin in phosphate buffer: implications for analytical and toxicological investigations.
Gäb J; John H; Blum MM
Toxicol Lett; 2011 Jan; 200(1-2):34-40. PubMed ID: 20979985
[TBL] [Abstract][Full Text] [Related]
10. Aging pathways for organophosphate-inhibited human butyrylcholinesterase, including novel pathways for isomalathion, resolved by mass spectrometry.
Li H; Schopfer LM; Nachon F; Froment MT; Masson P; Lockridge O
Toxicol Sci; 2007 Nov; 100(1):136-45. PubMed ID: 17698511
[TBL] [Abstract][Full Text] [Related]
11. Protein engineering of a human enzyme that hydrolyzes V and G nerve agents: design, construction and characterization.
Broomfield CA; Lockridge O; Millard CB
Chem Biol Interact; 1999 May; 119-120():413-8. PubMed ID: 10421478
[TBL] [Abstract][Full Text] [Related]
12. Human carboxylesterase 1 stereoselectively binds the nerve agent cyclosarin and spontaneously hydrolyzes the nerve agent sarin.
Hemmert AC; Otto TC; Wierdl M; Edwards CC; Fleming CD; MacDonald M; Cashman JR; Potter PM; Cerasoli DM; Redinbo MR
Mol Pharmacol; 2010 Apr; 77(4):508-16. PubMed ID: 20051531
[TBL] [Abstract][Full Text] [Related]
13. A molecular probe for the highly selective chromogenic detection of DFP, a mimic of Sarin and Soman nerve agents.
Gotor R; Costero AM; Gil S; Parra M; Martínez-Máñez R; Sancenón F
Chemistry; 2011 Oct; 17(43):11994-7. PubMed ID: 21922586
[No Abstract] [Full Text] [Related]
14. Human paraoxonase double mutants hydrolyze V and G class organophosphorus nerve agents.
Kirby SD; Norris JR; Richard Smith J; Bahnson BJ; Cerasoli DM
Chem Biol Interact; 2013 Mar; 203(1):181-5. PubMed ID: 23159884
[TBL] [Abstract][Full Text] [Related]
15. Enzymes for the homeland defense: optimizing phosphotriesterase for the hydrolysis of organophosphate nerve agents.
Tsai PC; Fox N; Bigley AN; Harvey SP; Barondeau DP; Raushel FM
Biochemistry; 2012 Aug; 51(32):6463-75. PubMed ID: 22809162
[TBL] [Abstract][Full Text] [Related]
16. Crystal structures of aged phosphonylated acetylcholinesterase: nerve agent reaction products at the atomic level.
Millard CB; Kryger G; Ordentlich A; Greenblatt HM; Harel M; Raves ML; Segall Y; Barak D; Shafferman A; Silman I; Sussman JL
Biochemistry; 1999 Jun; 38(22):7032-9. PubMed ID: 10353814
[TBL] [Abstract][Full Text] [Related]
17. Detection of human butyrylcholinesterase-nerve gas adducts by liquid chromatography-mass spectrometric analysis after in gel chymotryptic digestion.
Tsuge K; Seto Y
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jun; 838(1):21-30. PubMed ID: 16569519
[TBL] [Abstract][Full Text] [Related]
18. Detoxification of nerve agents by a substituted beta-cyclodextrin: application of a modified biological assay.
Wille T; Tenberken O; Reiter G; Müller S; Le Provost R; Lafont O; Estour F; Thiermann H; Worek F
Toxicology; 2009 Nov; 265(3):96-100. PubMed ID: 19800384
[TBL] [Abstract][Full Text] [Related]
19. Modifications to the organophosphorus nerve agent-protein adduct refluoridation method for retrospective analysis of nerve agent exposures.
Holland KE; Solano MI; Johnson RC; Maggio VL; Barr JR
J Anal Toxicol; 2008; 32(1):116-24. PubMed ID: 18269803
[TBL] [Abstract][Full Text] [Related]
20. Catalytic detoxification of nerve agent and pesticide organophosphates by butyrylcholinesterase assisted with non-pyridinium oximes.
Radić Z; Dale T; Kovarik Z; Berend S; Garcia E; Zhang L; Amitai G; Green C; Radić B; Duggan BM; Ajami D; Rebek J; Taylor P
Biochem J; 2013 Feb; 450(1):231-42. PubMed ID: 23216060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
